Haptena Therapeutics develops next-generation immunotherapies for oncogene-driven cancers, combining precision oncology with immune engineering. Its research focuses on…
Funding, investors, leadership and board, hiring signals, tech stack and corporate events for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see Haptena Therapeutics →Already a subscriber? Sign in
Xcout Intel tracks Haptena Therapeutics continuously — this profile deepens as new filings, funding, people and hiring data arrive.
Work at Haptena Therapeutics? Claim this profile